| Pharmaceuticals Industry | Healthcare Sector | Mr. Xin Wan CEO | SSE Exchange | CNE1000023Q8 ISIN |
| CN Country | 40,881 Employees | 3 Jul 2026 Last Dividend | 27 Jun 2024 Last Split | - IPO Date |
LBX Pharmacy Chain Joint Stock Company, previously known as Laobaixing Pharmacy Chain Joint Stock Company, is a prominent player in the pharmacy retail sector in China. Founded in 2001, the company has its headquarters in Changsha, China. Over the years, LBX Pharmacy Chain has expanded its reach across the country, establishing itself as a trusted name in the pharmaceutical retail industry. The company operates a chain of pharmacy stores, providing a wide range of pharmaceutical products and health-related services to the Chinese market.
LBX Pharmacy Chain delivers a comprehensive selection of prescription medications catering to various health conditions. This service is crucial for patients who require regular access to their prescribed medicines for ongoing health management.
For minor health issues and wellness needs, LBX offers an extensive range of over-the-counter drugs. These include medications for pain relief, cold and flu remedies, digestive health products, and more, providing customers with immediate access to treatments without the need for a prescription.
In addition to pharmaceuticals, the company stocks a wide variety of health and wellness products. This range encompasses dietary supplements, vitamins, and personal care items, supporting customers in maintaining a healthy lifestyle.
Recognizing the importance of professional guidance in health matters, LBX Pharmacy Chain provides consultation services. Customers can seek advice from qualified health professionals regarding medication use, potential side effects, and general health inquiries directly within the stores.